Close Menu Congressman Kurt Schrader

Health Care

The Hill
Health Care
40 House Democrats push for 'swift' action to lower drug prices

A group of 40 House Democrats is pressuring party leadership to act quickly on measures to lower prescription drug prices, highlighting the importance of the issue to the party, especially in an elect...

Read More
The historic plan adds Part D negotiations to framework of Schrader’s Reduced Costs and Continued Cures Act
Health Care
Schrader Announces Historic Deal to Lower Prescription Drug Prices Through the Build Back Better Act

Today, Rep. Kurt Schrader (OR-05) announced a historic deal he helped broker between House Democratic Leadership, the Senate and the White House that, if enacted as part of the Build Back Better Act, ...

Read More
The Lund Report
Health Care
Rep. Kurt Schrader Explains His Drug Pricing Plan

After gaining control of the White House and Congress in last year’s elections, Democrats appeared poised to deliver on their decades-long promise of negotiating drug prices for Medicare. But that ef...

Read More
Health Care
Schrader, Mullin Champion Bipartisan Bill to Improve Prescription Access for Seniors and Vulnerable Americans

Today, U.S. Representatives Kurt Schrader (D-OR-05) and Markwayne Mullin (R-OK-02) introduced the bipartisan Long-Term Care Pharmacy Definition Act of 2021. This commonsense legislation is the House c...

Read More
KATU
Health Care
Rep. Kurt Schrader speaks on Biden's $3.5 trillion spending plan

PORTLAND, Ore. — Joining KATU News' Your Voice Your Vote this week is U.S. Congressman Kurt Schrader who represents Oregon's 5th District. Recently, he and two other Democrats on the House Energy and ...

Read More
Wall Street Journal
Health Care
The Political Raid on Future Cures

It’s one of the strangest, and most destructive, juxtapositions in political history. Even as vaccines developed by drug companies are saving the world from Covid, the Democratic Party wants to rob th...

Read More
Health Care
Schrader, Peters Unveil Plan to Cut Patients’ Drug Costs and Preserve America’s Ability to Produce Life-Saving Cures

U.S. Representatives Kurt Schrader (OR-05) and Scott Peters (CA-52) introduced the Reduced Costs and Continued Cures Act (RCCCA) today to lower patients’ prescription drug costs and protect our nation...

Read More
Wall Street Journal
Health Care
Centrist House Democrats Offer Rival Proposal on Cutting Prescription Drug Prices

WASHINGTON—A pair of centrist House Democrats are expected to soon release their own proposal for lowering the cost of prescription-drug prices, as the party tries to close internal divisions over a ...

Read More
Axios
Health Care
Watch: A conversation on biosimilars and drug development

Link to interview On Thursday July 22, Axios senior editor Sam Baker and health care reporter Caitlin Owens discussed the future of biosimilars and other innovative approaches to lowering the cost of ...

Read More
Morning Consult
Health Care
Expanding Access to Biosimilars Has Bipartisan Support. But Movement on Legislation Hangs in the Balance of the Drug Pricing Debate

Advocates fear three bipartisan bills on lower-cost versions of biologic drugs will get caught up in H.R. 3 negotiations Despite bipartisan support to expand patient access to biosimilars, political ...

Read More